CNNE vs JAZZ · rev $198.4M vs P/E 1988, rev $2.28B
Cannae Holdings Inc (CNNE) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Cannae Holdings Inc (CNNE) is a restaurants company listed on NYSE.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported CNNE revenue for 2026-06-30 was $198.4M. Net income was $5.4M. CNNE currently screens at market cap $622.4M.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
CNNE currently screens at market cap $622.4M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the CNNE and JAZZ stock pages for the full models.
Not investment advice.